| # | Drug | Count |
|---|---|---|
| 0 | NEVIRAPINE | 16 |
| 1 | LAMIVUDINE | 6 |
| 2 | LAMIVUDINE ORAL | 6 |
| 3 | IBUPFROFEN | 4 |
| 4 | IBUPROFEN | 4 |
| 5 | IBUPROFEN 200 MG | 4 |
| 6 | IBUPROFEN 200MG | 4 |
| 7 | IBUPROFEN CAPSULE | 4 |
| 8 | IBUPROFEN CAPSULES 200 MG | 4 |
| 9 | IBUPROFEN ORAL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEVIRAPINE | 16 | 0.0018 |
| 1 | LAMIVUDINE | 6 | 0.0002 |
| 2 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 3 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 4 | OFLOXACIN OTIC | 1 | 0.0001 |
| 5 | OFLOXACIN | 1 | 0.0001 |
| 6 | CEFDINIR | 1 | 0.0001 |
| 7 | ADALIMUMAB-AATY | 2 | 0.0000 |
| 8 | PACLITAXEL | 3 | 0.0000 |
| 9 | TRASTUZUMAB | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0007 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 4 | Anticholinergic [EPC] | 1 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 2 | 0.0000 |